A detailed history of Onyx Bridge Wealth Group LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Onyx Bridge Wealth Group LLC holds 5,124 shares of ABBV stock, worth $872,873. This represents 0.16% of its overall portfolio holdings.

Number of Shares
5,124
Previous 5,101 0.45%
Holding current value
$872,873
Previous $874,000 15.68%
% of portfolio
0.16%
Previous 0.15%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$163.84 - $199.33 $3,768 - $4,584
23 Added 0.45%
5,124 $1.01 Million
Q2 2024

Jul 22, 2024

SELL
$154.79 - $180.76 $2,941 - $3,434
-19 Reduced 0.37%
5,101 $874,000
Q1 2024

Apr 29, 2024

BUY
$159.82 - $182.1 $21,735 - $24,765
136 Added 2.73%
5,120 $932,000
Q4 2023

Jan 31, 2024

BUY
$137.6 - $154.97 $1,926 - $2,169
14 Added 0.28%
4,984 $772,000
Q3 2023

Oct 16, 2023

SELL
$133.59 - $154.65 $93,913 - $108,718
-703 Reduced 12.39%
4,970 $740,000
Q2 2023

Jul 25, 2023

BUY
$132.51 - $164.9 $280,258 - $348,763
2,115 Added 59.44%
5,673 $764,000
Q1 2023

Apr 10, 2023

BUY
$144.61 - $166.54 $15,039 - $17,320
104 Added 3.01%
3,558 $567,000
Q4 2022

Jan 11, 2023

SELL
$138.31 - $165.87 $12,171 - $14,596
-88 Reduced 2.48%
3,454 $0
Q3 2022

Oct 13, 2022

BUY
$134.21 - $153.93 $258,622 - $296,623
1,927 Added 119.32%
3,542 $496,000
Q2 2022

Jul 25, 2022

SELL
$137.62 - $174.96 $66,332 - $84,330
-482 Reduced 22.99%
1,615 $240,000
Q1 2022

May 09, 2022

SELL
$131.98 - $163.75 $32,203 - $39,955
-244 Reduced 10.42%
2,097 $331,000
Q4 2021

Jan 18, 2022

BUY
$107.43 - $135.93 $5,049 - $6,388
47 Added 2.05%
2,341 $317,000
Q3 2021

Oct 20, 2021

SELL
$106.4 - $120.78 $11,065 - $12,561
-104 Reduced 4.34%
2,294 $246,000
Q2 2021

Jul 20, 2021

BUY
$105.21 - $117.21 $252,293 - $281,069
2,398 New
2,398 $282,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Onyx Bridge Wealth Group LLC Portfolio

Follow Onyx Bridge Wealth Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Onyx Bridge Wealth Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Onyx Bridge Wealth Group LLC with notifications on news.